 Spinal cord schistosomiasis clinical laboratory radiological study note therapeutic aspects Fourteen patients schistosomiasis spinal cord groups patients clinical computer-assisted myelographic evidence lesions conus medullaris cauda equina clinical picture patients acute subacute transverse myelitis normal equivocal CT myelographic appearances Granulomas bilharzial ova female patients conus ova haematobium second unidentified bilharzial ova presumptive diagnosis spinal cord schistosomiasis patients characteristic clinical investigative profiles patients evidence bilharzial infection positive blood serology detection bilharzial ova patient following abnormalities CSF examination pleocytosis elevated protein content presence oligoclonal IgG bands IgG index CSF IgG synthesis rate CSF bilharzia enzyme-linked immunosorbent assay ELISA test presence schistosomal infection theca sensitive specific diagnosis spinal cord schistosomiasis Eleven patients rapid clinical improvement praziquantel corticosteroid treatment operation Significant reductions CSF cell count protein concentration bilharzia ELISA titre intrathecal antibody production praziquantel corticosteroid therapy CSF sugar level significant rise reduction conus size patients CT myelography medical therapy normalization laboratory parameters combined medical treatment praziquantel corticosteroids clinical radiological improvement presumptive diagnosis cord schistosomiasis policy early intensive medical treatment surgical therapy condition indirect evidence